Price-file publication check · 45 CFR § 180
F · 55
This hospital's published file contains little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
24,049
Insurances with rates
12
CPT / HCPCS codes
14,178
Most expensive procedures (gross)
25682-028-01
$150,797
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114]
Gross
$231,996
50242-554-01
$87,208
OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN [202948]
Gross
$134,166
50242-150-01
$80,954
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [178568]
Gross
$124,545
0173-0898-03
$49,510
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [191781]
Gross
$76,169
79952-110-01
$43,992
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [191773]
Gross
$67,681
27800254
$38,754
HC BRACHYTHERAPY SOURCE_ NONSTRANDED_YTTRIUM_90_ PER SOURCE 125967
Gross
$59,621
27800078
$36,624
HC COCHLEAR DIVICE_ W ALL INTERNAL _ EXTERNAL COMPONENTS
Gross
$56,344
82705-010-01
$34,815
EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION [198486]
Gross
$53,561
50242-918-01
$34,276
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION [185087]
Gross
$52,732
57894-650-02
$30,756
GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION [202938]
Gross
$47,317
48100323
$27,083
HC ECMO_ECLS DAILY MANAGEMENT EA DAY VENO_ARTERIAL
Gross
$41,666
50242-105-01
$26,211
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION [185710]
Gross
$40,325
0006-3026-04
$26,181
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519]
Gross
$40,278
0074-5015-01
$25,900
RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION [195203]
Gross
$39,846
0006-3026-01
$25,167
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519]
Gross
$38,719
0006-3026-02
$24,972
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519]
Gross
$38,419
50242-917-01
$24,160
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [175551]
Gross
$37,169
0003-2327-11
$23,058
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [150563]
Gross
$35,474
0310-4611-50
$22,728
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [179453]
Gross
$34,966
51144-030-01
$22,487
ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION [187476]
Gross
$34,595
61755-008-01
$22,407
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [183555]
Gross
$34,472
0003-3734-13
$22,270
NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION [169181]
Gross
$34,262
57894-503-01
$21,963
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [188662]
Gross
$33,790
48100337
$21,540
HC TTVI_RPLCMT PROSTC VLV PERQ W_R HRT CATH_ANGRPH
Gross
$33,139
48100347
$21,540
HC TRANSCAROTID TAVR
Gross
$33,139
48100348
$21,540
HC TMVI W_PROSTHETIC VALVE PERCUTANEOUS APPROACH
Gross
$33,139
72903-853-01
$21,019
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [195098]
Gross
$32,336
36000548
$20,565
HC TRLUML PERIPHERAL ATHERECTOMY ILIAC
Gross
$31,639
48100305
$20,565
HC PRQ TCAT CLSR CGEN VENTR SEPRAL DFCT W_IMPLT
Gross
$31,639
48100340
$20,514
HC INSJ PERQ VAD W_RS_I R HEART VENOUS ACCESS ONLY
Gross
$31,561
15054-1120-4
$20,200
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861]
Gross
$31,077
48100293
$20,151
HC ENDOVASCULAR OPEN_PERCUT TIBIAL_PERONEAL_ STENT_ARTHER W ANGIOPLASTY
Gross
$31,001
48100202
$19,890
HC TRANSCATH MV REPAIR_ PC APPROACH_ INCLUDE TRANSSEPTAL PUNCTURE WHEN PERFORMED_ INIT_L PROSTHESIS
Gross
$30,600
48100315
$19,890
HC REVASCULARIZATION INTRAVASCULAR LITHOTRIPSY _ STENT _ ATHERECTOMY
Gross
$30,600
48100317
$19,890
HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ STENT
Gross
$30,600
48100318
$19,890
HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ ATHERECTOMY
Gross
$30,600
48100319
$19,890
HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ STENT_ATHERECTOMY
Gross
$30,600
48100321
$19,890
HC PERC TRANSCATH CLOSURE_ NON CONG _POST_INFARCT_ VENT SEPTAL DEFECT W_IMPLANT
Gross
$30,600
48100338
$19,890
HC TTVR PERCUTANEOUS APPROACH INITIAL PROSTHESIS
Gross
$30,600
64764-300-20
$19,666
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [166819]
Gross
$30,255
36100032
$19,656
HC PERCUTANEOUS TRANSLUMINAL MECHANICAL THROMBECTOMY AND_OR INFUSION FOR THROMBOLYSIS_ DIALYSIS
Gross
$30,240
59572-775-01
$18,473
LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [187194]
Gross
$28,420
36000704
$18,072
HC RMVL LUNG OTHER THAN PNEUMONECTOMY 1 LOBE LOBECT
Gross
$27,802
36100160
$18,072
HC TCAT IV STENT CRV CRTD ART W_O EMBOLIC PROTECJ
Gross
$27,802
50242-070-01
$17,881
OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION [165108]
Gross
$27,509
30000240
$17,600
HC ONC PAN_TUM DNA_RNA GNRJ SEQ
Gross
$27,077
48100349
$16,155
HC TRANSCATHETER PLACEMENT_SBSQ REMOVAL CEPD PERQ
Gross
$24,854
50242-145-01
$16,088
PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION [157879]
Gross
$24,750
36000762
$15,967
HC REVSC EVSC FPVT ATHRC SF 1ST
Gross
$24,565
36000764
$15,967
HC REVSC EVSC FPVT ATHRC CPLX 1
Gross
$24,565
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 25682-028-01 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114] | $231,996 | $150,797 | — | — | 0 |
| 50242-554-01 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN [202948] | $134,166 | $87,208 | — | — | 0 |
| 50242-150-01 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [178568] | $124,545 | $80,954 | — | — | 0 |
| 0173-0898-03 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [191781] | $76,169 | $49,510 | — | — | 0 |
| 79952-110-01 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [191773] | $67,681 | $43,992 | — | — | 0 |
| 27800254 | HC BRACHYTHERAPY SOURCE_ NONSTRANDED_YTTRIUM_90_ PER SOURCE 125967 | $59,621 | $38,754 | — | — | 0 |
| 27800078 | HC COCHLEAR DIVICE_ W ALL INTERNAL _ EXTERNAL COMPONENTS | $56,344 | $36,624 | — | — | 0 |
| 82705-010-01 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION [198486] | $53,561 | $34,815 | — | — | 0 |
| 50242-918-01 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION [185087] | $52,732 | $34,276 | — | — | 0 |
| 57894-650-02 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION [202938] | $47,317 | $30,756 | — | — | 0 |
| 48100323 | HC ECMO_ECLS DAILY MANAGEMENT EA DAY VENO_ARTERIAL | $41,666 | $27,083 | — | — | 0 |
| 50242-105-01 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION [185710] | $40,325 | $26,211 | — | — | 0 |
| 0006-3026-04 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519] | $40,278 | $26,181 | — | — | 0 |
| 0074-5015-01 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION [195203] | $39,846 | $25,900 | — | — | 0 |
| 0006-3026-01 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519] | $38,719 | $25,167 | — | — | 0 |
| 0006-3026-02 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519] | $38,419 | $24,972 | — | — | 0 |
| 50242-917-01 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [175551] | $37,169 | $24,160 | — | — | 0 |
| 0003-2327-11 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [150563] | $35,474 | $23,058 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [179453] | $34,966 | $22,728 | — | — | 0 |
| 51144-030-01 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION [187476] | $34,595 | $22,487 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [183555] | $34,472 | $22,407 | — | — | 0 |
| 0003-3734-13 | NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION [169181] | $34,262 | $22,270 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [188662] | $33,790 | $21,963 | — | — | 0 |
| 48100337 | HC TTVI_RPLCMT PROSTC VLV PERQ W_R HRT CATH_ANGRPH | $33,139 | $21,540 | — | — | 0 |
| 48100347 | HC TRANSCAROTID TAVR | $33,139 | $21,540 | — | — | 0 |
| 48100348 | HC TMVI W_PROSTHETIC VALVE PERCUTANEOUS APPROACH | $33,139 | $21,540 | — | — | 0 |
| 72903-853-01 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [195098] | $32,336 | $21,019 | — | — | 0 |
| 36000548 | HC TRLUML PERIPHERAL ATHERECTOMY ILIAC | $31,639 | $20,565 | — | — | 0 |
| 48100305 | HC PRQ TCAT CLSR CGEN VENTR SEPRAL DFCT W_IMPLT | $31,639 | $20,565 | — | — | 0 |
| 48100340 | HC INSJ PERQ VAD W_RS_I R HEART VENOUS ACCESS ONLY | $31,561 | $20,514 | — | — | 0 |
| 15054-1120-4 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861] | $31,077 | $20,200 | — | — | 0 |
| 48100293 | HC ENDOVASCULAR OPEN_PERCUT TIBIAL_PERONEAL_ STENT_ARTHER W ANGIOPLASTY | $31,001 | $20,151 | — | — | 0 |
| 48100202 | HC TRANSCATH MV REPAIR_ PC APPROACH_ INCLUDE TRANSSEPTAL PUNCTURE WHEN PERFORMED_ INIT_L PROSTHESIS | $30,600 | $19,890 | — | — | 0 |
| 48100315 | HC REVASCULARIZATION INTRAVASCULAR LITHOTRIPSY _ STENT _ ATHERECTOMY | $30,600 | $19,890 | — | — | 0 |
| 48100317 | HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ STENT | $30,600 | $19,890 | — | — | 0 |
| 48100318 | HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ ATHERECTOMY | $30,600 | $19,890 | — | — | 0 |
| 48100319 | HC REVASCASCULARIZATION INTRAVASCULAR LITHOTRIPSY_ TIBIAL_PERONEAL _ STENT_ATHERECTOMY | $30,600 | $19,890 | — | — | 0 |
| 48100321 | HC PERC TRANSCATH CLOSURE_ NON CONG _POST_INFARCT_ VENT SEPTAL DEFECT W_IMPLANT | $30,600 | $19,890 | — | — | 0 |
| 48100338 | HC TTVR PERCUTANEOUS APPROACH INITIAL PROSTHESIS | $30,600 | $19,890 | — | — | 0 |
| 64764-300-20 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [166819] | $30,255 | $19,666 | — | — | 0 |
| 36100032 | HC PERCUTANEOUS TRANSLUMINAL MECHANICAL THROMBECTOMY AND_OR INFUSION FOR THROMBOLYSIS_ DIALYSIS | $30,240 | $19,656 | — | — | 0 |
| 59572-775-01 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [187194] | $28,420 | $18,473 | — | — | 0 |
| 36000704 | HC RMVL LUNG OTHER THAN PNEUMONECTOMY 1 LOBE LOBECT | $27,802 | $18,072 | — | — | 0 |
| 36100160 | HC TCAT IV STENT CRV CRTD ART W_O EMBOLIC PROTECJ | $27,802 | $18,072 | — | — | 0 |
| 50242-070-01 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION [165108] | $27,509 | $17,881 | — | — | 0 |
| 30000240 | HC ONC PAN_TUM DNA_RNA GNRJ SEQ | $27,077 | $17,600 | — | — | 0 |
| 48100349 | HC TRANSCATHETER PLACEMENT_SBSQ REMOVAL CEPD PERQ | $24,854 | $16,155 | — | — | 0 |
| 50242-145-01 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION [157879] | $24,750 | $16,088 | — | — | 0 |
| 36000762 | HC REVSC EVSC FPVT ATHRC SF 1ST | $24,565 | $15,967 | — | — | 0 |
| 36000764 | HC REVSC EVSC FPVT ATHRC CPLX 1 | $24,565 | $15,967 | — | — | 0 |
Showing top 50 of 24,049 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.